NSE - Delayed Quote INR

Innova Captab Limited (INNOVACAP.NS)

Compare
1,005.00
-14.35
(-1.41%)
At close: 3:29 PM GMT+5:30
Loading Chart for INNOVACAP.NS
DELL
  • Previous Close 1,019.35
  • Open 1,025.90
  • Bid --
  • Ask --
  • Day's Range 983.55 - 1,029.90
  • 52 Week Range 421.35 - 1,060.00
  • Volume 148,221
  • Avg. Volume 120,321
  • Market Cap (intraday) 57.511B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 44.02
  • EPS (TTM) 22.83
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1,031.00

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

innovacaptab.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: INNOVACAP.NS

View More

Performance Overview: INNOVACAP.NS

Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INNOVACAP.NS
122.30%
S&P BSE SENSEX
9.42%

1-Year Return

INNOVACAP.NS
122.30%
S&P BSE SENSEX
19.82%

3-Year Return

INNOVACAP.NS
122.30%
S&P BSE SENSEX
38.41%

5-Year Return

INNOVACAP.NS
122.30%
S&P BSE SENSEX
92.69%

Compare To: INNOVACAP.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INNOVACAP.NS

View More

Valuation Measures

Annual
As of 11/27/2024
  • Market Cap

    58.33B

  • Enterprise Value

    60.70B

  • Trailing P/E

    44.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.97

  • Price/Book (mrq)

    6.52

  • Enterprise Value/Revenue

    5.17

  • Enterprise Value/EBITDA

    32.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.05%

  • Return on Assets (ttm)

    7.59%

  • Return on Equity (ttm)

    18.43%

  • Revenue (ttm)

    11.78B

  • Net Income Avi to Common (ttm)

    1.18B

  • Diluted EPS (ttm)

    22.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    181.35M

  • Total Debt/Equity (mrq)

    29.17%

  • Levered Free Cash Flow (ttm)

    -1.84B

Research Analysis: INNOVACAP.NS

View More

Company Insights: INNOVACAP.NS

Research Reports: INNOVACAP.NS

View More

People Also Watch